[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Sorrell et al., 2009 - Google Patents

National Institutes of Health consensus development conference statement: management of hepatitis B

Sorrell et al., 2009

View HTML
Document ID
5036842006154836139
Author
Sorrell M
Belongia E
Costa J
Gareen I
Grem J
Inadomi J
Kern E
McHugh J
Petersen G
Rein M
Strader D
Trotter H
Publication year
Publication venue
Annals of internal medicine

External Links

Snippet

Vaccines for hepatitis B virus have resulted in a substantial decline in the number of new cases of acute hepatitis B in the United States, but this success has not yet been duplicated worldwide. To more closely examine this topic, the National Institutes of Health (NIH) …
Continue reading at www.acpjournals.org (HTML) (other versions)

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G06F19/322Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work
    • G06Q50/24Patient record management
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/576Immunoassay; Biospecific binding assay for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/10Office automation, e.g. computer aided management of electronic mail or groupware; Time management, e.g. calendars, reminders, meetings or time accounting
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F3/00Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
    • G06F3/01Input arrangements or combined input and output arrangements for interaction between user and computer

Similar Documents

Publication Publication Date Title
Sorrell et al. National Institutes of Health consensus development conference statement: management of hepatitis B
Hatzakis et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference
Cuadrado et al. Microenvironment eradication of hepatitis C: a novel treatment paradigm
Falade-Nwulia et al. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review
Lee et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study
Strom et al. Eliminating the public health problem of hepatitis B and C in the United States: phase one report
Scaglione et al. Effectiveness of hepatitis B treatment in clinical practice
Seeff et al. The National Institutes of Health Consensus Development Conference: Management of Hepatitis C 2002
Aleman et al. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C–associated liver cirrhosis
Afdhal et al. The new paradigm of hepatitis C therapy: integration of oral therapies into best practices
Janssen et al. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
Lo Re III et al. Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study
Spradling et al. Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996–2007
Lee et al. Community and personal risk factors for hepatitis C virus infection: a survey of 23 820 residents in Taiwan in 1991–2
Grint et al. Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA
Stepanova et al. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity
Harris Jr et al. Successful integration of hepatitis C evaluation and treatment services with methadone maintenance
Cunningham et al. Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people who inject drugs
Choi et al. Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
US Preventive Services Task Force* Screening for hepatitis C virus infection in adults: recommendation statement
McPherson et al. Targeted case finding for hepatitis B using dry blood spot testing in the British–Chinese and South Asian populations of the North‐East of England
Wang et al. Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir
McGovern et al. Acute hepatitis C virus infection in incarcerated injection drug users
Sølund et al. Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation
Min Thaung et al. Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus‐co‐infected patients in Myanmar